The role of bariatric surgery in the management of nonalcoholic steatohepatitis

Volume: 37, Issue: 3, Pages: 208 - 215
Published: Mar 19, 2021
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States and increasing globally. The progressive form of NAFLD, nonalcoholic steatohepatitis (NASH), can lead to cirrhosis and complications of end-stage liver disease. No FDA-approved therapy for NAFLD/NASH exists. Treatment of NAFLD/NASH includes effective and sustained life-style modification and weight loss. This review reports on the recent...
Paper Details
Title
The role of bariatric surgery in the management of nonalcoholic steatohepatitis
Published Date
Mar 19, 2021
Volume
37
Issue
3
Pages
208 - 215
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.